// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Risk Factors for Symptomatic Avascular Necrosis in Childhood-Onset Systemic Lupus Erythematous

Sathish Kumar - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Inflammatory Myositis or Diabetic Myonecrosis?: A Case Study

Douglas Smith - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: 52 Week Safety and Efficacy in an Open-Label, Long-Term Extension Study

Youb Chalabi - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Baricitinib

Rheumatologist- Views and Perceived Barriers to using Patient Decision Aids in Clinical Practice

John Esdaile - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acquired immunodeficiency syndrome

N/A

Assessing Significant Flares in Rheumatoid Arthritis: Validity of the Outcome Measures in Rheumatology Preliminary Flare Questions in the Canadian Early Arthritis Cohort

Clifton Bingham - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Prevalence of Inflammatory Back Pain in PsA: The PREPARE Study

Dafna Gladman - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Can Satisfactory Reliability of the 7-Joint Ultrasound Score be Attained by Inexperienced Readers in a Single Calibration Exercise? Results from the BIODAM Program

Stephanie Werner - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Do Sustained Clinical Remission and Sustained Low Disease Activity Equally Predict Functional Status in Early Rheumatoid Arthritis?

Pooneh Akhavan - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Association of Ethnicity and Self-Reported Hip Pain among Caucasian and Chinese in Vancouver: A Population-Based Study

John Esdaile - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Etanercept-Methotrexate Combination Therapy Compared with Etanercept Monotherapy in Rheumatoid Arthritis Patients with Moderate or Severe Disease in the CAMEO Trial

Boulos Haraoui - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Clinical and Radiographic Outcomes in Patients with Rheumatoid Arthritis Treated with Etanercept or Etanercept + Methotrexate: Two-Year Results from the Canadian Methotrexate and Etanercept Outcome Study (CAMEO)

Carter Thorne - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

In RA, 14-3-3? Positive Serum is Associated with More Severe Disease and its Levels Inform Response to Anti-TNF Therapy

Kieu Lam - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rheumatologists of Tomorrow: One Schoo-s Story

Nader Khalidi - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

A Comparison of Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) Trial Design: Ways to Improve the Number of Positive Trials in SLE

Janet Pope - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Patient Medication Knowledge and Satisfaction with Inflammatory Arthritis Medication Information as Justification for Pharmacist-Led Education Program

Carolyn Johns - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Causes of Mortality in Lupus Patients followed Prospectively at the University of Toronto Lupus Clinic

Dominique Ibanez - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Myocardial infarction

N/A

ECG Abnormalities in a Cohort of Systemic Sclerosis Patients

Murray Baron - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Mortality in Canadian Systemic Sclerosis Patients: Cause for Alarm.

Marie Hudson - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Practical Learning about Inflammatory Arthritis Improves the Precision of Patient- Referral in Rheumatology. Results of PRADA, a Regional CME Activity in Sherbrooke (Quebec) Ariel

Alexandre Hamelin - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Improved Clinical Control of a Challenging Case of Behcets Disease with Rituximab Therapy

Anna Oswald - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Rituximab

Copyright © 2026. QuantiNova All rights reserved